Financhill
Back

Trevi Therapeutics Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRVI is experiencing selling pressure, which indicates risk of future bearish movement.

Trevi Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 4.17 Sell
20-day SMA: 3.35 Buy
50-day SMA: 3.15 Buy
200-day SMA: 2.98 Buy
8-day EMA: 3.95 Buy
20-day EMA: 3.56 Buy
50-day EMA: 3.26 Buy
200-day EMA: 2.91 Buy

Trevi Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.33 Buy
Relative Strength Index (14 RSI): 63.29 Buy
Chaikin Money Flow: -255608 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.59 - 3.91) Buy
Bollinger Bands (100): (2.7 - 3.48) Buy

Trevi Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Trevi Therapeutics Stock

Is Trevi Therapeutics Stock a Buy?

TRVI Technical Analysis vs Fundamental Analysis

Sell
49
Trevi Therapeutics (TRVI) is a Sell

Is Trevi Therapeutics a Buy or a Sell?

Trevi Therapeutics Stock Info

Market Cap:
307.5M
Price in USD:
4.00
Share Volume:
441.5K

Trevi Therapeutics 52-Week Range

52-Week High:
4.68
52-Week Low:
1.27
Sell
49
Trevi Therapeutics (TRVI) is a Sell

Trevi Therapeutics Share Price Forecast

Is Trevi Therapeutics Stock a Buy?

  • Trevi Therapeutics share price is 4.00 while TRVI 8-day exponential moving average is 3.95, which is a Buy signal.
  • The stock price of TRVI is 4.00 while Trevi Therapeutics 20-day EMA is 3.56, which makes it a Buy.
  • Trevi Therapeutics 50-day exponential moving average is 3.26 while TRVI share price is 4.00, making it a Buy technically.
  • TRVI stock price is 4.00 and Trevi Therapeutics 200-day simple moving average is 2.91, creating a Buy signal.

Fundamental Analysis of Trevi Therapeutics

Is Trevi Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and an increase next year of $0.00 per share.

Technical Analysis of Trevi Therapeutics

Should I short Trevi Therapeutics stock?

* Trevi Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.